1)Kobayashi S, Yano T, Matsumoto Y et al:Clinic and epidemiologic analysis of giant cell(temporal)arteritis from a nationwide survey in 1998 in Japan:the first government-supported nationwide survey. Arthritis Rheum 49:594-598, 2007
2)Salvarani C, Cantini F, Hunder GG:Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234- 245, 2008
3)Hayreh SS, Podhajsky PA, Zimmerman B:Ocular manifestation of giant cell arteritis. Am J Ophthalmol 125:509-520, 1998
4)松髙 恵・杉田圭二郎・雑候正義:リウマチ性多発筋痛症に両眼性動脈炎型前部虚血性視神経症を合併した1例.臨眼69:885-890,2015
5)Okumura T, Tannno S, Ohhira M et al:The rate of polymyalgia rheumatica(PMR)and remitting seronegative symmetrical synovitis with pitting edema(RS3PE)syndrome in a clinics where primary care physicians are working in the Japan. Rheumatol Int 32:1695-1699, 2012
6)Bird HA, Esselincxx W, Dxxon ASTJD:An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434-439, 1979
7)Nordborg E, Nordborg C:Giant cell arteritis:strategies in diagnosis and treatment. Curr Opin Rheumatol 16:25-30, 2004
8)Blockmans D:Diagnosis and extension of giant cell arteritis. Contribution of imaging techniques. Presse Med 41:948-954, 2012
9)Singh AG, Kermani TA, Crowson CS et al:Visual manifestations in giant cell arteritis:trend over 5 decades in a population-based cohort. J Rheumatol 309-315, 2015
10)Partain K, Bradley J, Brandt KD:Polymyalgia rheumatica and giant cell arteritis. Indiana Med 81:11-16, 1998
11)Liu GT, Glaser JS, Schatz NJ et al:Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 101:1779-1785, 1994
12)Danesh-Meyer H, Savino PJ, Gamble GG:Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 112:1098-1103, 2005
13)棚野一郎・木ノ内玲子・大谷慎一・他:ステロイドパルス療法が奏功した後に長期経過で視力が低下した巨細胞性動脈炎による前部虚血性視神経症.眼科53:1769-1773,2011
14)日本循環器学会・他:側頭動脈炎(巨細胞性動脈炎).循環器病の診断と治療に関するガイドライン(2006-2007年度悟道研究班報告)血管炎症候群の診療ガイドライン(解説).Circulation Journal 72:1253-1346, 2008